Amyloidosis: open trials in Poland

• NCT06128629

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  Trial Treatment · Phase 3 · Intellia Therapeutics

  Uniwersyteckie Centrum Kliniczne, Gdansk · Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy, Warsaw

  Registry updated 2026-11-04

• NCT07207811

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Uniwersyteckie Centrum Kliniczne, Gdansk · Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego, Poznan · Instytut Kardiologii im. Prymasa Tysiąclecia Stefana Kardynała Wyszyńskiego, Warsaw

  Registry updated 2026-10-21

• NCT07052903

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Trial Treatment · Phase 3 · Alnylam Pharmaceuticals

  Instytut Centrum Zdrowia Matki Polki, Lodz

  Registry updated 2026-10-20

• NCT05667493

  An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

  Trial Treatment · Phase 3 · Ionis Pharmaceuticals, Inc.

  Krakowski Szpital Specjalistyczny im. Jana Pawła II, Kraków

  Registry updated 2026-04-17

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error